Recent Finacing
Recent Raise
G.ST Antivirals, spun out of Medical University of Vienna, develops host-directed antivirals (e.g., 2‑deoxyglucose) targeting viral metabolic/nucleotide supply for respiratory viruses, collaborating with Takeda on COVID-19.